Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS has been designated a EULAR Centre of Excellence 2020-2025, in recognition of our continued high-quality research publications in rheumatology.

Two members of staff shake hands, celebrating that NDORMS has been named a European Centre of Excellence

EULAR, the European League Against Rheumatism, represents patients, health professionals and scientific societies of rheumatology of all European nations. It aims to reduce the burden of rheumatic diseases on the individual and society and to improve the treatment, prevention and rehabilitation of musculoskeletal diseases. 

EULAR Centres of Excellence are top rheumatology research units in Europe aiming to develop a group of first-class research centres for active researchers and enable exchange of fellows and research projects.

NDORMS, with the Botnar Research Centre and Kennedy Institute of Rheumatology, is one of the largest and most dynamic multidisciplinary academic rheumatology research centres in the world, with over 50 dedicated researchers focusing on rheumatic conditions.

We have one of the largest and broadest groupings of translational rheumatology research in the world; covering inflammatory, degenerative and congenital diseases of the musculoskeletal system. Scientific approaches include direct patient-focused research, epidemiology, and basic mechanistic research in immunology, genetics, bone, matrix and cartilage biology.

Professor Paul Bowness, Lead for the Oxford EULAR Centre of Excellence, said: “We are delighted with this award and the recognition it brings to our research in rheumatic conditions that affect the lives of millions of people around the world. We will continue our mission to develop and deliver excellent research to help patients now and in the future.”

Similar stories

New Associate Professors announced at NDORMS

The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.